ID   MIOX_MOUSE              Reviewed;         285 AA.
AC   Q9QXN5; Q5S8D0; Q91WQ8;
DT   12-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2005, sequence version 2.
DT   22-JUL-2015, entry version 120.
DE   RecName: Full=Inositol oxygenase;
DE            EC=1.13.99.1;
DE   AltName: Full=Aldehyde reductase-like 6;
DE   AltName: Full=Myo-inositol oxygenase;
DE            Short=MI oxygenase;
DE   AltName: Full=Renal-specific oxidoreductase;
GN   Name=Miox; Synonyms=Aldrl6, Rsor;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=10944187; DOI=10.1073/pnas.160266197;
RA   Yang Q., Dixit B., Wada J., Tian Y., Wallner E.I., Srivastva S.K.,
RA   Kanwar Y.S.;
RT   "Identification of a renal-specific oxido-reductase in newborn
RT   diabetic mice.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9896-9901(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6; TISSUE=Kidney;
RX   PubMed=15504367; DOI=10.1016/j.bbrc.2004.09.209;
RA   Arner R.J., Prabhu K.S., Reddy C.C.;
RT   "Molecular cloning, expression, and characterization of myo-inositol
RT   oxygenase from mouse, rat, and human kidney.";
RL   Biochem. Biophys. Res. Commun. 324:1386-1392(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH IRON AND
RP   MYO-INOSITOL, AND COFACTOR.
RX   PubMed=17012379; DOI=10.1073/pnas.0605143103;
RA   Brown P.M., Caradoc-Davies T.T., Dickson J.M., Cooper G.J.,
RA   Loomes K.M., Baker E.N.;
RT   "Crystal structure of a substrate complex of myo-inositol oxygenase, a
RT   di-iron oxygenase with a key role in inositol metabolism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15032-15037(2006).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH IRON AND
RP   MYO-INOSITOL, AND COFACTOR.
RX   PubMed=18364358; DOI=10.1074/jbc.M800348200;
RA   Thorsell A.G., Persson C., Voevodskaya N., Busam R.D., Hammarstrom M.,
RA   Graslund S., Graslund A., Hallberg B.M.;
RT   "Structural and biophysical characterization of human myo-inositol
RT   oxygenase.";
RL   J. Biol. Chem. 283:15209-15216(2008).
CC   -!- CATALYTIC ACTIVITY: Myo-inositol + O(2) = D-glucuronate + H(2)O.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000269|PubMed:17012379,
CC         ECO:0000269|PubMed:18364358};
CC       Note=Binds 2 iron ions per subunit. {ECO:0000269|PubMed:17012379,
CC       ECO:0000269|PubMed:18364358};
CC   -!- PATHWAY: Polyol metabolism; myo-inositol degradation into D-
CC       glucuronate; D-glucuronate from myo-inositol: step 1/1.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Kidney specific. Renal proximal tubules.
CC       {ECO:0000269|PubMed:10944187}.
CC   -!- SIMILARITY: Belongs to the myo-inositol oxygenase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF197127; AAF25202.1; -; mRNA.
DR   EMBL; AY738257; AAV65815.1; -; mRNA.
DR   EMBL; BC013543; AAH13543.1; -; mRNA.
DR   CCDS; CCDS27745.1; -.
DR   RefSeq; NP_064361.2; NM_019977.2.
DR   UniGene; Mm.158200; -.
DR   PDB; 2HUO; X-ray; 2.00 A; A=1-285.
DR   PDB; 3BXD; X-ray; 2.00 A; A=1-285.
DR   PDBsum; 2HUO; -.
DR   PDBsum; 3BXD; -.
DR   ProteinModelPortal; Q9QXN5; -.
DR   SMR; Q9QXN5; 28-285.
DR   IntAct; Q9QXN5; 1.
DR   MINT; MINT-4102022; -.
DR   STRING; 10090.ENSMUSP00000023282; -.
DR   PhosphoSite; Q9QXN5; -.
DR   REPRODUCTION-2DPAGE; Q9QXN5; -.
DR   MaxQB; Q9QXN5; -.
DR   PaxDb; Q9QXN5; -.
DR   PRIDE; Q9QXN5; -.
DR   DNASU; 56727; -.
DR   Ensembl; ENSMUST00000023282; ENSMUSP00000023282; ENSMUSG00000022613.
DR   GeneID; 56727; -.
DR   KEGG; mmu:56727; -.
DR   UCSC; uc007xgc.1; mouse.
DR   CTD; 55586; -.
DR   MGI; MGI:1891725; Miox.
DR   eggNOG; NOG135479; -.
DR   GeneTree; ENSGT00390000016211; -.
DR   HOGENOM; HOG000163182; -.
DR   HOVERGEN; HBG039556; -.
DR   InParanoid; Q9QXN5; -.
DR   KO; K00469; -.
DR   OMA; NFYREQH; -.
DR   OrthoDB; EOG7DZ8KD; -.
DR   PhylomeDB; Q9QXN5; -.
DR   TreeFam; TF300089; -.
DR   BRENDA; 1.13.99.1; 3474.
DR   SABIO-RK; Q9QXN5; -.
DR   UniPathway; UPA00111; UER00527.
DR   EvolutionaryTrace; Q9QXN5; -.
DR   NextBio; 313210; -.
DR   PRO; PR:Q9QXN5; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   Bgee; Q9QXN5; -.
DR   CleanEx; MM_MIOX; -.
DR   ExpressionAtlas; Q9QXN5; baseline and differential.
DR   Genevisible; Q9QXN5; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0016234; C:inclusion body; ISS:UniProtKB.
DR   GO; GO:0004033; F:aldo-keto reductase (NADP) activity; IDA:UniProtKB.
DR   GO; GO:0008199; F:ferric iron binding; ISS:UniProtKB.
DR   GO; GO:0050113; F:inositol oxygenase activity; ISS:UniProtKB.
DR   GO; GO:0050661; F:NADP binding; IEA:Ensembl.
DR   GO; GO:0016491; F:oxidoreductase activity; TAS:MGI.
DR   GO; GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; IDA:UniProtKB.
DR   GO; GO:0016701; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen; ISS:UniProtKB.
DR   GO; GO:0019310; P:inositol catabolic process; ISS:UniProtKB.
DR   InterPro; IPR018170; Aldo/ket_reductase_CS.
DR   InterPro; IPR007828; Inositol_oxygenase.
DR   PANTHER; PTHR12588; PTHR12588; 1.
DR   Pfam; PF05153; DUF706; 1.
DR   PROSITE; PS00063; ALDOKETO_REDUCTASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Iron; Metal-binding;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN         1    285       Inositol oxygenase.
FT                                /FTId=PRO_0000079149.
FT   REGION       85     88       Substrate binding.
FT   REGION      141    142       Substrate binding.
FT   REGION      220    221       Substrate binding.
FT   METAL        98     98       Iron 1. {ECO:0000269|PubMed:17012379,
FT                                ECO:0000269|PubMed:18364358}.
FT   METAL       123    123       Iron 1. {ECO:0000269|PubMed:17012379,
FT                                ECO:0000269|PubMed:18364358}.
FT   METAL       124    124       Iron 1. {ECO:0000269|PubMed:17012379,
FT                                ECO:0000269|PubMed:18364358}.
FT   METAL       124    124       Iron 2. {ECO:0000269|PubMed:17012379,
FT                                ECO:0000269|PubMed:18364358}.
FT   METAL       194    194       Iron 2. {ECO:0000269|PubMed:17012379,
FT                                ECO:0000269|PubMed:18364358}.
FT   METAL       220    220       Iron 2. {ECO:0000269|PubMed:17012379,
FT                                ECO:0000269|PubMed:18364358}.
FT   METAL       253    253       Iron 1. {ECO:0000269|PubMed:17012379,
FT                                ECO:0000269|PubMed:18364358}.
FT   BINDING      29     29       Substrate.
FT   BINDING     127    127       Substrate.
FT   CONFLICT     65     65       S -> G (in Ref. 1; AAF25202).
FT                                {ECO:0000305}.
FT   STRAND       31     33       {ECO:0000244|PDB:2HUO}.
FT   HELIX        37     50       {ECO:0000244|PDB:2HUO}.
FT   HELIX        53     63       {ECO:0000244|PDB:2HUO}.
FT   HELIX        73     79       {ECO:0000244|PDB:2HUO}.
FT   HELIX        80     82       {ECO:0000244|PDB:2HUO}.
FT   HELIX        95    109       {ECO:0000244|PDB:2HUO}.
FT   HELIX       114    122       {ECO:0000244|PDB:2HUO}.
FT   HELIX       125    132       {ECO:0000244|PDB:2HUO}.
FT   HELIX       136    138       {ECO:0000244|PDB:2HUO}.
FT   STRAND      145    148       {ECO:0000244|PDB:2HUO}.
FT   TURN        155    159       {ECO:0000244|PDB:2HUO}.
FT   HELIX       165    168       {ECO:0000244|PDB:2HUO}.
FT   TURN        170    172       {ECO:0000244|PDB:2HUO}.
FT   STRAND      173    176       {ECO:0000244|PDB:2HUO}.
FT   HELIX       185    187       {ECO:0000244|PDB:2HUO}.
FT   HELIX       194    204       {ECO:0000244|PDB:2HUO}.
FT   HELIX       211    219       {ECO:0000244|PDB:2HUO}.
FT   HELIX       223    226       {ECO:0000244|PDB:2HUO}.
FT   TURN        232    234       {ECO:0000244|PDB:2HUO}.
FT   HELIX       237    255       {ECO:0000244|PDB:2HUO}.
FT   HELIX       264    278       {ECO:0000244|PDB:2HUO}.
SQ   SEQUENCE   285 AA;  33164 MW;  C6877BFF2B60D1A7 CRC64;
     MKVDVGPDPS LVYRPDVDPE MAKSKDSFRN YTSGPLLDRV FTTYKLMHTH QTVDFVSRKR
     IQYGSFSYKK MTIMEAVGML DDLVDESDPD VDFPNSFHAF QTAEGIRKAH PDKDWFHLVG
     LLHDLGKIMA LWGEPQWAVV GDTFPVGCRP QASVVFCDST FQDNPDLQDP RYSTELGMYQ
     PHCGLENVLM SWGHDEYLYQ MMKFNKFSLP SEAFYMIRFH SFYPWHTGGD YRQLCSQQDL
     DMLPWVQEFN KFDLYTKCPD LPDVESLRPY YQGLIDKYCP GTLSW
//
